Balrampur Chini Mills Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 8:22 pm

Quick Insight

Balrampur Chini Mills Ltd, currently priced at ₹589 with a market capitalization of ₹11,899 crore, shows a price-to-earnings ratio of 27.2, suggesting a premium valuation relative to its earnings. The company's return on equity (ROE) stands at 12.1%, while return on capital employed (ROCE) is at 11.1%, indicating efficient capital utilization. With an operating profit margin (OPM) of 24%, the firm demonstrates solid profitability. However, its borrowings of ₹2,627 crore against reserves of ₹3,775 crore highlight a manageable debt load, reflected in an interest coverage ratio (ICR) of 11.55x. Given the substantial institutional ownership—12.19% from foreign institutional investors and 22.58% from domestic institutions—investors may find Balrampur Chini a compelling addition to their portfolios, particularly in a recovering sugar market.

Competitors of Balrampur Chini Mills Ltd

All Competitor Stocks of Balrampur Chini Mills Ltd

Quarterly Result

Last Updated: May 31, 2025, 9:42 am

Below is a detailed analysis of the quarterly data for Balrampur Chini Mills Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 1,504.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,192.00 Cr. (Dec 2024) to 1,504.00 Cr., marking an increase of 312.00 Cr..
• For Expenses, as of Mar 2025, the value is 1,138.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,068.00 Cr. (Dec 2024) to 1,138.00 Cr., marking an increase of 70.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 365.00 Cr.. The value appears strong and on an upward trend. It has increased from 124.00 Cr. (Dec 2024) to 365.00 Cr., marking an increase of 241.00 Cr..
• For OPM %, as of Mar 2025, the value is 24.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Dec 2024) to 24.00%, marking an increase of 14.00%.
• For Other Income, as of Mar 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Dec 2024) to 20.00 Cr., marking an increase of 4.00 Cr..
• For Interest, as of Mar 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Dec 2024) to 30.00 Cr., marking an increase of 23.00 Cr..
• For Depreciation, as of Mar 2025, the value is 43.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 44.00 Cr. (Dec 2024) to 43.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 312.00 Cr.. The value appears strong and on an upward trend. It has increased from 89.00 Cr. (Dec 2024) to 312.00 Cr., marking an increase of 223.00 Cr..
• For Tax %, as of Mar 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Dec 2024) to 26.00%, marking an increase of 5.00%.
• For Net Profit, as of Mar 2025, the value is 229.00 Cr.. The value appears strong and on an upward trend. It has increased from 70.00 Cr. (Dec 2024) to 229.00 Cr., marking an increase of 159.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 11.35. The value appears strong and on an upward trend. It has increased from 3.49 (Dec 2024) to 11.35, marking an increase of 7.86.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 6:00 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:24 pm

Below is a detailed analysis of the balance sheet data for Balrampur Chini Mills Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00 Cr..
• For Reserves, as of Mar 2025, the value is 3,775.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,381.00 Cr. (Mar 2024) to 3,775.00 Cr., marking an increase of 394.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2,627.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2,009.00 Cr. (Mar 2024) to 2,627.00 Cr., marking an increase of 618.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 707.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 678.00 Cr. (Mar 2024) to 707.00 Cr., marking an increase of 29.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 7,129.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,088.00 Cr. (Mar 2024) to 7,129.00 Cr., marking an increase of 1,041.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 2,645.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,639.00 Cr. (Mar 2024) to 2,645.00 Cr., marking an increase of 6.00 Cr..
• For CWIP, as of Mar 2025, the value is 106.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2024) to 106.00 Cr., marking an increase of 60.00 Cr..
• For Investments, as of Mar 2025, the value is 431.00 Cr.. The value appears strong and on an upward trend. It has increased from 339.00 Cr. (Mar 2024) to 431.00 Cr., marking an increase of 92.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,947.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,064.00 Cr. (Mar 2024) to 3,947.00 Cr., marking an increase of 883.00 Cr..
• For Total Assets, as of Mar 2025, the value is 7,129.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,088.00 Cr. (Mar 2024) to 7,129.00 Cr., marking an increase of 1,041.00 Cr..

Notably, the Reserves (3,775.00 Cr.) exceed the Borrowings (2,627.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Balrampur Chini Mills Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 26.49. This value is within the healthy range. It has increased from 13.94 (Mar 23) to 26.49, marking an increase of 12.55.
• For Diluted EPS (Rs.), as of Mar 24, the value is 26.49. This value is within the healthy range. It has increased from 13.94 (Mar 23) to 26.49, marking an increase of 12.55.
• For Cash EPS (Rs.), as of Mar 24, the value is 33.44. This value is within the healthy range. It has increased from 19.93 (Mar 23) to 33.44, marking an increase of 13.51.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 168.57. It has increased from 143.52 (Mar 23) to 168.57, marking an increase of 25.05.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 168.57. It has increased from 143.52 (Mar 23) to 168.57, marking an increase of 25.05.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 277.26. It has increased from 231.27 (Mar 23) to 277.26, marking an increase of 45.99.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 47.89. This value is within the healthy range. It has increased from 28.49 (Mar 23) to 47.89, marking an increase of 19.40.
• For PBIT / Share (Rs.), as of Mar 24, the value is 39.64. This value is within the healthy range. It has increased from 22.07 (Mar 23) to 39.64, marking an increase of 17.57.
• For PBT / Share (Rs.), as of Mar 24, the value is 35.50. This value is within the healthy range. It has increased from 19.66 (Mar 23) to 35.50, marking an increase of 15.84.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 25.20. This value is within the healthy range. It has increased from 13.51 (Mar 23) to 25.20, marking an increase of 11.69.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 26.49. This value is within the healthy range. It has increased from 14.09 (Mar 23) to 26.49, marking an increase of 12.40.
• For PBDIT Margin (%), as of Mar 24, the value is 17.27. This value is within the healthy range. It has increased from 12.31 (Mar 23) to 17.27, marking an increase of 4.96.
• For PBIT Margin (%), as of Mar 24, the value is 14.29. This value is within the healthy range. It has increased from 9.54 (Mar 23) to 14.29, marking an increase of 4.75.
• For PBT Margin (%), as of Mar 24, the value is 12.80. This value is within the healthy range. It has increased from 8.50 (Mar 23) to 12.80, marking an increase of 4.30.
• For Net Profit Margin (%), as of Mar 24, the value is 9.08. This value is within the healthy range. It has increased from 5.84 (Mar 23) to 9.08, marking an increase of 3.24.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.55. This value is within the healthy range. It has increased from 6.09 (Mar 23) to 9.55, marking an increase of 3.46.
• For Return on Networth / Equity (%), as of Mar 24, the value is 15.71. This value is within the healthy range. It has increased from 9.81 (Mar 23) to 15.71, marking an increase of 5.90.
• For Return on Capital Employeed (%), as of Mar 24, the value is 20.16. This value is within the healthy range. It has increased from 12.85 (Mar 23) to 20.16, marking an increase of 7.31.
• For Return On Assets (%), as of Mar 24, the value is 8.78. This value is within the healthy range. It has increased from 5.23 (Mar 23) to 8.78, marking an increase of 3.55.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.09. This value is below the healthy minimum of 0.2. It has decreased from 0.14 (Mar 23) to 0.09, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.59. This value is within the healthy range. It has decreased from 0.64 (Mar 23) to 0.59, marking a decrease of 0.05.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.97. It has increased from 0.94 (Mar 23) to 0.97, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 24, the value is 1.43. This value is below the healthy minimum of 1.5. It has increased from 1.31 (Mar 23) to 1.43, marking an increase of 0.12.
• For Quick Ratio (X), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 1. It has decreased from 0.13 (Mar 23) to 0.07, marking a decrease of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.77. This value is below the healthy minimum of 4. It has increased from 1.51 (Mar 23) to 1.77, marking an increase of 0.26.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 11.32. This value is below the healthy minimum of 20. It has decreased from 17.89 (Mar 23) to 11.32, marking a decrease of 6.57.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 8.63. This value is below the healthy minimum of 20. It has decreased from 12.29 (Mar 23) to 8.63, marking a decrease of 3.66.
• For Earning Retention Ratio (%), as of Mar 24, the value is 88.68. This value exceeds the healthy maximum of 70. It has increased from 82.11 (Mar 23) to 88.68, marking an increase of 6.57.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 91.37. This value exceeds the healthy maximum of 70. It has increased from 87.71 (Mar 23) to 91.37, marking an increase of 3.66.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 11.55. This value is within the healthy range. It has decreased from 11.82 (Mar 23) to 11.55, marking a decrease of 0.27.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 7.08. This value is within the healthy range. It has increased from 6.60 (Mar 23) to 7.08, marking an increase of 0.48.
• For Enterprise Value (Cr.), as of Mar 24, the value is 9,300.53. It has decreased from 9,855.99 (Mar 23) to 9,300.53, marking a decrease of 555.46.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.66. This value is within the healthy range. It has decreased from 2.11 (Mar 23) to 1.66, marking a decrease of 0.45.
• For EV / EBITDA (X), as of Mar 24, the value is 9.63. This value is within the healthy range. It has decreased from 17.15 (Mar 23) to 9.63, marking a decrease of 7.52.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has decreased from 1.71 (Mar 23) to 1.30, marking a decrease of 0.41.
• For Retention Ratios (%), as of Mar 24, the value is 88.67. This value exceeds the healthy maximum of 70. It has increased from 82.10 (Mar 23) to 88.67, marking an increase of 6.57.
• For Price / BV (X), as of Mar 24, the value is 2.15. This value is within the healthy range. It has decreased from 2.76 (Mar 23) to 2.15, marking a decrease of 0.61.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has decreased from 1.71 (Mar 23) to 1.30, marking a decrease of 0.41.
• For EarningsYield, as of Mar 24, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 23) to 0.07, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness